Topic: Pharma Labels

16Oct/18

Roche and SQZ Biotech Expand Cell Therapy Partnership to Develop Antigen Presenting Cells

SQZ Biotechnologies (SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, is expanding its collaboration with Roche in cellular therapy. Under the terms, SQZ and Roche will jointly develop andRead More…

12Sep/18

Chasing top HIV players, Merck scores FDA approval for 2 new drugs

After marquee HIV drug approvals last year for Gilead and GlaxoSmithKline, Merck will follow into the crowded market with two new meds. The drugmaker scored FDA approvals for a new non-nucleoside reverse transcriptase inhibitor calledRead More…

11Jul/18

Mylan Launches Generic Version Of The Novartis Exelon Patch

Mylan N.V. today announced the U.S. launch of Rivastigmine Transdermal System, 4.6 mg/24 hrs, 9.5 mg/24 hrs and 13.3 mg/24 hrs, a generic version of Novartis’ Exelon Patch. Mylan received final approval fromRead More…

11Aug/13

FDA May Soon Allow Generic Drug Makers to Update Safety Information On Pharmaceutical Labels

A Pharmaceutical Label Can Be Updated Sooner by Marie Ellis of Medical News Today Present Food and Drug Administration (FDA) regulations prohibit generic drug manufacturers from updating a product’s safety on theRead More…